Get the Stockscreener App
2.04
0.97%
-0.02
Pre-market:
2.05
0.010
+0.49%
Gri Bio Inc stock is traded at $2.04, with a volume of 31,663.
It is down -0.97% in the last 24 hours and down -11.88% over the past month.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
See More
Previous Close:
$2.06
Open:
$2.15
24h Volume:
31,663
Relative Volume:
0.41
Market Cap:
$3.61M
Revenue:
-
Net Income/Loss:
$-11.96M
P/E Ratio:
-0.0244
EPS:
-83.7383
Net Cash Flow:
$-10.19M
1W Performance:
-8.52%
1M Performance:
-11.88%
6M Performance:
-96.32%
1Y Performance:
-93.93%
1-Day Range:
$1.98
$2.15
1-Week Range:
$1.98
$2.25
52-Week Range:
$1.97
$80.36
Gri Bio Inc Stock (GRI) Company Profile
Name
Gri Bio Inc
Sector
Industry
Phone
(619) 400-1171
Address
2223 AVENIDA DE LA PLAYA, LA JOLLA
Compare GRI vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRI
Gri Bio Inc
|
2.04 | 3.65M | 0 | -11.96M | -10.19M | -83.74 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Gri Bio Inc Stock (GRI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-24 | Initiated | H.C. Wainwright | Buy |
Gri Bio Inc Stock (GRI) Latest News
GRI Bio Inc. Q1 2026 Earnings: EPS Misses Estimates as Development-Stage Company Faces HeadwindsEPS Consistency Score - The Legal Advocate
GRI Bio Inc. (GRI) Slides 7% as Shares Test Key Support at $1.96Relative Volume - Newser
GRI Bio (GRI) Q1 2026 Results Miss Estimates — EPS $-1.61 vs $-0.91Positive Surprise Momentum - Newser
GRI Bio CEO to discuss innovative immune therapies at healthcare showcase May 20 - Pluang
Biotech GRI Bio to outline NKT-cell drug pipeline in live webcast - Stock Titan
Number of shareholders of GRI Bio, Inc. – NASDAQ:GRI - TradingView
GRI Bio (GRI) Falls -5.56% — Watching $1.94 Support 2026-05-15Sector Rotation - Newser
GRI Bio Reports Positive Phase 2a Results for GRI-0621 in IPF and Advances Immune-Modulating Pipeline with Strong Q1 2026 Financials - Minichart
GRI Bio Highlights Promising Phase 2a IPF Data, Outlook - TipRanks
GRI Bio reports phase 2a data for IPF drug candidate GRI-0621 - Investing.com
GRI Bio Q1 net loss narrows on lower R&D expenses - TradingView
IPF Phase 2a results and cash runway update for GRI Bio (NASDAQ: GRI) - Stock Titan
GRI Bio Reports First Quarter 2026 Financial Results, New - GlobeNewswire
H.C. Wainwright Maintains GRI Bio(GRI.US) With Buy Rating, Maintains Target Price $10 - Moomoo
GRI BIO ($GRI) Releases Q1 2026 Earnings - Moomoo
GRI Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
GRI Bio (GRI) Schedule 13G/A: 90,475 shares represent 5.9% stake - Stock Titan
GRI Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
GRI Bio (NASDAQ: GRI) Q1 loss narrows as cash runway extends into 2027 - Stock Titan
Is GRI Bio (GRI) stock hiding in plain sight? (+1.78%) 2026-05-11Low Volatility Stocks - Newser
GRI Stock Price, Quote & Chart | GRI BIO INC (NASDAQ:GRI) - ChartMill
GRI Bio (GRI) Stock: Is It a Good Portfolio Addition | Q4 2025: Earnings UnderperformReal Trader Insights - newser.com
GRI Bio announces 1-for-28 reverse share split - MSN
GRI Bio (GRI) Stock Consumer Data (-3.14%) 2026-04-24Oversold Bounce - Newser
GRI Bio (GRI) Stock Volume Drought (Tick Down) 2026-04-20Verified Analyst Reports - Cổng thông tin điện tử tỉnh Lào Cai
Market Valuation Insight | GRI Bio reports 294.6% EPS miss and zero revenueEarnings Trend Analysis - Newser
GRI | GRI Bio, Inc. Common Insider Trading - Quiver Quantitative
GRI Bio (GRI) Stock Volume Analysis (Grinds Higher) 2026-04-15Portfolio Ideas - UBND thành phố Hải Phòng
Is GRI Bio (GRI) Stock at a Peak | Price at $2.33, Down 4.90%Day Trade Opportunities - Newser
Revenue Check: What makes Friedman Industries Incorporated stock attractive today2026 Highlights & Daily Market Momentum Tracking - baoquankhu1.vn
GRI Bio (GRI) price target decreased by 75.16% to 163.20 - MSN
GRI Bio receives UAE patent for inflammatory disease treatment By Investing.com - Investing.com Australia
Big Picture: Can Euro Tech Holdings Company Limited continue delivering strong returns2026 Sentiment & Community Shared Stock Ideas - baoquankhu1.vn
GRI Springs on UAE Patent - Baystreet.ca
GRI Bio receives UAE patent for inflammatory disease treatment - Investing.com
GRI Bio Receives Notice of Allowance for UAE Patent - GlobeNewswire
Sentiment Review: Is GRI Bio Inc forming a bullish divergence2026 Snapshot & Capital Efficiency Focused Ideas - baoquankhu1.vn
Aug Movers: Is GRI Bio Inc forming a bullish divergence2026 Big Picture & Real-Time Market Sentiment Reports - baoquankhu1.vn
12 Health Care Stocks Moving In Tuesday's Pre-Market SessionAditxt (NASDAQ:ADTX), Advanced Biomed (NAS - Benzinga
GRI Bio Inc. (GRI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Options Flow: Is GRI Bio Inc forming a double bottom2026 Weekly Recap & Stepwise Trade Execution Plans - baoquankhu1.vn
Aug Technicals: Is GRI Bio Inc in a long term uptrend2026 Gainers & AI Driven Price Predictions - baoquankhu1.vn
Options Flow: Can GRI Bio Inc reach all time highs this yearTrade Exit Summary & Smart Money Movement Tracker - baoquankhu1.vn
GRI Bio (NASDAQ:GRI) versus NeoGenomics (NASDAQ:NEO) Financial Contrast - Defense World
Trend Review: Can GRI Bio Inc be recession proof2026 Market Mood & Detailed Earnings Play Strategies - baoquankhu1.vn
Portfolio Recap: Is GRI Bio Inc a top pick in the sectorMarket Activity Recap & Weekly Return Optimization Plans - baoquankhu1.vn
Aug Outlook: Can GRI Bio Inc keep up with sector leaders2026 Final Week & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Movement Recap: Is GRI Bio Inc a momentum stock2026 Setups & Weekly Consistent Profit Watchlists - baoquankhu1.vn
If You Invested $1,000 in GRI Bio (GRI) - Stock Titan
Analyst Calls: Is GRI Bio Inc a top pick in the sectorPortfolio Performance Summary & AI Forecasted Stock Moves - baoquankhu1.vn
AI Investing InsightsOfficial HomepageIntellectia AI™ - intellectia.ai
Gri Bio Inc Stock (GRI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):